Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001386769 | SCV001587117 | pathogenic | Cerebral creatine deficiency syndrome | 2022-08-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1073697). This variant has not been reported in the literature in individuals affected with GAMT-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala103Profs*11) in the GAMT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAMT are known to be pathogenic (PMID: 15108290). |
Fulgent Genetics, |
RCV002504647 | SCV002811119 | likely pathogenic | Deficiency of guanidinoacetate methyltransferase | 2024-05-30 | criteria provided, single submitter | clinical testing |